Julio A. Urbina

Caracas, A, Bolivarian Republic of Venezuela

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.

New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.

Journal: BMJ open

Published: January 01, 2022

Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease.

Higher oral efficacy of ravuconazole in self-nanoemulsifying systems in shorter treatment in experimental chagas disease.

Journal: Experimental parasitology

Published: September 21, 2020

Emerging agents for the treatment of Chagas disease: what is in the preclinical and clinical development pipeline?

Emerging agents for the treatment of Chagas disease: what is in the preclinical and clinical development pipeline?

Journal: Expert opinion on investigational drugs

Published: July 09, 2020

Effect of Posaconazole in an in vitro model of cardiac fibrosis induced by Trypanosoma cruzi.

Effect of Posaconazole in an in vitro model of cardiac fibrosis induced by Trypanosoma cruzi.

Journal: Molecular and biochemical parasitology

Published: November 20, 2019

Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region.

Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region.

Journal: The Lancet. Infectious diseases

Published: June 02, 2018

In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis.

In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis.

Journal: The Journal of antimicrobial chemotherapy

Published: December 07, 2017

The long road towards a safe and effective treatment of chronic Chagas disease.

The long road towards a safe and effective treatment of chronic Chagas disease.

Journal: The Lancet. Infectious diseases

Published: September 01, 2017

Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity.

Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity.

Journal: International journal of nanomedicine

Published: May 30, 2017

Pharmacodynamics and Follow-Up Period in the Treatment of Human Trypanosoma Cruzi Infections With Posaconazole.

Pharmacodynamics and Follow-Up Period in the Treatment of Human Trypanosoma Cruzi Infections With Posaconazole.

Journal: Journal of the American College of Cardiology

Published: March 16, 2017

Congenital Chagas' disease transmission in the United States: Diagnosis in adulthood.

Congenital Chagas' disease transmission in the United States: Diagnosis in adulthood.

Journal: IDCases

Published: June 23, 2016

Benznidazole for Chronic Chagas' Cardiomyopathy.

Benznidazole for Chronic Chagas' Cardiomyopathy.

Journal: The New England journal of medicine

Published: January 14, 2016

Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.

Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.

Journal: Antimicrobial agents and chemotherapy

Published: November 19, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026